Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pierce

Showing results (581-590 of 595) with videos related to

Pageof 60
Sort By:
Blood Advances|April 7, 2020
Outcomes of older patients with NPM1-mutated AML: current treatments and the promise of venetoclax-based regimensCurtis A Lachowiez, Sanam Loghavi, Tapan M Kadia, et al.
Blood Advances|April 25, 2020
Clinical value of event-free survival in acute myeloid leukemiaAbhishek Maiti, Hagop M Kantarjian, Vinita Popat, et al.
Nature|October 18, 2019
A large source of cloud condensation nuclei from new particle formation in the tropicsChristina J Williamson, Agnieszka Kupc, Duncan Axisa, et al.
Science Advances|December 10, 2025
Enhanced radiative cooling by large aerosol particles from wildfire-driven thunderstormsYaowei Li, John A Dykema, David A Peterson, et al.
Space Science Reviews|November 24, 2025
Europa Clipper Magnetometer Boom Deployment: A First Look at the Magnetometer Observations of the Spacecraft and the Interplanetary Magnetic FieldCorey J Cochrane, Steven P Joy, Haje Korth, et al.
PNAS Nexus|January 15, 2024
COVID-19 perturbation on US air quality and human health impact assessmentJian He, Colin Harkins, Katelyn O'Dell, et al.
Blood Advances|February 7, 2020
Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromesGuillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Christopher B Benton, et al.
Blood Cancer Journal|September 22, 2023
Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agentsDanielle Hammond, Sanam Loghavi, Sa A Wang, et al.
American Journal of Human Genetics|November 22, 2022
A recurrent de novo splice site variant involving DNM1 exon 10a causes developmental and epileptic encephalopathy through a dominant-negative mechanismShridhar Parthasarathy, Sarah McKeown Ruggiero, Antoinette Gelot, et al.
Physical Review Letters|June 3, 2022
Improved Limit on Tensor Currents in the Weak Interaction from ^{8}Li β DecayM T Burkey, G Savard, A T Gallant, et al.
Pageof 60

Showing results (581-590 of 595) with videos related to

Sort By:
Pageof 60
Blood Advances|April 7, 2020
Outcomes of older patients with NPM1-mutated AML: current treatments and the promise of venetoclax-based regimensCurtis A Lachowiez, Sanam Loghavi, Tapan M Kadia, et al.
Blood Advances|April 25, 2020
Clinical value of event-free survival in acute myeloid leukemiaAbhishek Maiti, Hagop M Kantarjian, Vinita Popat, et al.
Nature|October 18, 2019
A large source of cloud condensation nuclei from new particle formation in the tropicsChristina J Williamson, Agnieszka Kupc, Duncan Axisa, et al.
Science Advances|December 10, 2025
Enhanced radiative cooling by large aerosol particles from wildfire-driven thunderstormsYaowei Li, John A Dykema, David A Peterson, et al.
Space Science Reviews|November 24, 2025
Europa Clipper Magnetometer Boom Deployment: A First Look at the Magnetometer Observations of the Spacecraft and the Interplanetary Magnetic FieldCorey J Cochrane, Steven P Joy, Haje Korth, et al.
PNAS Nexus|January 15, 2024
COVID-19 perturbation on US air quality and human health impact assessmentJian He, Colin Harkins, Katelyn O'Dell, et al.
Blood Advances|February 7, 2020
Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromesGuillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Christopher B Benton, et al.
Blood Cancer Journal|September 22, 2023
Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agentsDanielle Hammond, Sanam Loghavi, Sa A Wang, et al.
American Journal of Human Genetics|November 22, 2022
A recurrent de novo splice site variant involving DNM1 exon 10a causes developmental and epileptic encephalopathy through a dominant-negative mechanismShridhar Parthasarathy, Sarah McKeown Ruggiero, Antoinette Gelot, et al.
Physical Review Letters|June 3, 2022
Improved Limit on Tensor Currents in the Weak Interaction from ^{8}Li β DecayM T Burkey, G Savard, A T Gallant, et al.
Pageof 60